Previous studies have shown that PLXNB1 can induce epithelial-mesenchymal transformation (EMT) and promote metastasis of head and neck squamous cell carcinoma [26], and NRP2 can promote tumor progression of thyroid papillary carcinoma [27]. Here, PLXNB1 is linked to head and neck squamous cell carcinoma.